I also expected more of an increase in EBITDA. Especially when you consider the small amount that was expected from the coors distribution agreement and the transition from contract to own brand brewing.
the Coors deal alone was touted to bring in 3/4m annually in ebitda.
- Forums
- ASX - By Stock
- GDA
- Ann: H1 FY23 Results
Ann: H1 FY23 Results, page-8
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
Add GDA (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
-0.005(1.85%) |
Mkt cap ! $35.01M |
Open | High | Low | Value | Volume |
27.5¢ | 27.5¢ | 26.5¢ | $816 | 3.068K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 4347 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.265 |
7 | 139570 | 0.260 |
2 | 100021 | 0.255 |
2 | 14223 | 0.250 |
1 | 3660 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 4347 | 1 |
0.285 | 3865 | 1 |
0.290 | 22375 | 2 |
0.300 | 7941 | 1 |
0.310 | 5481 | 2 |
Last trade - 10.54am 10/10/2024 (20 minute delay) ? |
Featured News
GDA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online